Skye Bioscience, Inc. (SKYE) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Skye Bioscience, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.233 -- 00:00:02.736 Ladies and gentlemen, thank you for standing by. 00:00:02.736 -- 00:00:05.800 My name is Jordan, and I'll be your conference operator today. 00:00:05.800 -- 00:00:11.206 At this time, I would like to welcome everyone to the Sky Bioscience third quarter 2025 00:00:11.206 -- 00:00:14.631 financial results and business update call. 00:00:14.631 -- 00:00:18.115 All lines have been placed on mute to prevent any background noise. 00:00:18.115 -- 00:00:21.319 After the speaker's remarks, there will be a question and answer session. 00:00:21.319 -- 00:00:26.285 I would now like to turn the conference over to Bernie Hertel, head of investor relations. 00:00:26.285 -- 00:00:28.906 Please go ahead. 00:00:29.512 -- 00:00:33.018 Hello, and thank you all for participating in today's call. 00:00:33.018 -- 00:00:37.166 Before we begin, I'd like to caution that comments made during this conference call will 00:00:37.166 -- 00:00:40.632 contain forward-looking statements under the safe harbor provisions of the U.S. 00:00:40.632 -- 00:00:44.600 Private Securities Litigation Reform Act of 1995, including 00:00:44.600 -- 00:00:48.467 statements about Sky's expectations regarding its development activities, timelines, 00:00:48.467 -- 00:00:50.251 and milestones. 00:00:50.251 -- 00:00:53.776 Forward-looking statements are subject to risks and uncertainties that could cause actual 00:00:53.776 -- 00:00:58.402 results to differ materially and adversely, and reported results should not be considered 00:00:58.402 -- 00:01:01.225 as an indication of future performance. 00:01:01.225 -- 00:01:04.870 These forward-looking statements speak only as of today's date, and the company undertakes 00:01:04.870 -- 00:01:08.034 no obligation to revise or update any statem...